Weight Management Protocol
AdipotideComplete dosing & administration guide
A targeted fat-destroying peptide that works like a smart missile, cutting off blood supply to fat cells and causing rapid weight loss in primate studies.
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Dose Range
0.25-0.25mg/kg
Frequency
Once daily
Route
Subcutaneous injection
Cycle Length
4-6 weeks
Dosing
How much
do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Starting Dose
0.10 mg/kg
Adipotide is research-only and has never been approved for people. These numbers come from a dose-finding study in obese monkeys, where the dose was raised step by step every 2 weeks. The first human Phase 1 study started even lower, at 0.03 mg/kg daily. [2]
Standard Dose
0.25 mg/kg
Middle step in the monkey dose-finding study. Not an approved human dose. [2]
Advanced Dose
0.43 mg/kg
This was the best-working ("optimal") dose in obese monkeys, leading to about 10.6% body-weight loss over 28 days. It is from animal research and is not an approved or established human dose. [2]
Timing
Best time to take
Morning, at a consistent time each day
With food?
Can be administered with or without food. Ensure adequate hydration throughout the day.
If stacking
If using BPC-157 for potential renal support, administer at a different time of day. Avoid combining with other nephrotoxic substances.
Adjusting Your Dose
Increase if
- +Tolerating current dose well with stable kidney markers
- +Minimal side effects after 1-2 weeks
- +Fat loss progress has plateaued at current dose
- +Serum creatinine remains within normal range
Decrease if
- -Serum creatinine rises above normal range
- -Significant proteinuria or glucosuria develops
- -Signs of dehydration despite adequate fluid intake
- -Any concerning changes in urination patterns
Signs of right dose
- ✓Steady fat loss of 2-3% body weight per week
- ✓Stable kidney function markers
- ✓Improved insulin sensitivity on bloodwork
- ✓No significant side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Administration
How do I
use it?
Reconstitution
What you need
- •Bacteriostatic water (BAC water)
- •Insulin syringe (29-31 gauge)
- •Alcohol swabs
- •Sterile vial of Adipotide powder
- •Calculator for dose calculation based on body weight
Injection
Route
Subcutaneous injection once daily
Best sites
- •Abdomen (2 inches from navel)
- •Front of thigh (middle third)
- •Upper arm (outer area)
Technique
- 1.Calculate your dose based on body weight and verify the math
- 2.Clean injection site thoroughly with alcohol swab and let dry
- 3.Pinch skin to create a fold at the injection site
- 4.Insert needle at 45-90 degree angle depending on body composition
- 5.Inject slowly and steadily
- 6.Remove needle and apply light pressure - do not rub
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Adipotide has been extensively studied in mice, rats, and three species of primates with consistent results. The primary safety concern is dose-dependent kidney effects, which were reversible upon stopping treatment in all studies. No cardiovascular, neurological, or hepatic adverse events were observed. The compound shows remarkable selectivity - lean animals given the same doses experienced no weight loss, suggesting it specifically targets excess fat tissue.
Safety data comes from well-designed primate studies published in peer-reviewed journals including Science Translational Medicine. However, there are no human clinical trials, so the full safety profile in humans remains unknown. The reversibility of kidney effects in primates is encouraging but requires validation in human studies.
Common Side Effects
Experienced by some users
Elevated Serum Creatinine
The most consistently observed effect in primate studies, indicating the kidneys are processing the compound.
Management: Monitor with regular blood tests. Usually normalizes within 4 weeks of stopping treatment. Stay well-hydrated.
Proteinuria
Mild to moderate protein appearing in urine, reflecting kidney filtration changes.
Management: Monitor with urinalysis. Reduce dose if marked. Ensure adequate hydration.
Glucosuria
Glucose appearing in urine even with normal blood sugar, due to effects on kidney tubules.
Management: Monitor blood glucose to ensure it remains normal. Not typically concerning if blood sugar is stable.
Reduced Appetite
Decreased food intake observed in all treated animals - appears to be genuine appetite reduction rather than nausea.
Management: Ensure adequate protein intake despite reduced appetite. This effect contributes to weight loss.
Less Common
- •Mild Dehydration
- •Injection Site Reactions
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Serum creatinine rises significantly above your baseline
- ×Marked proteinuria that persists or worsens
- ×Signs of kidney problems (pain in lower back, changes in urination)
- ×Severe or persistent dehydration despite adequate fluid intake
- ×Any allergic reaction (rash, swelling, difficulty breathing)
- ×Completion of the recommended 4-week treatment cycle
Adipotide is a research compound without FDA approval. Use only under medical supervision with regular kidney function monitoring. Stop immediately and consult a healthcare provider if you experience any concerning symptoms.
Interactions
With other peptides
- ✓BPC-157 - May provide protective effects for kidneys - consider using for support
- ✓TB-500 - No known interactions, but avoid adding kidney stress
- !AOD-9604 - Both target fat loss through different mechanisms - use caution with combination
- !Semaglutide - Different mechanisms but overlapping goals - not recommended to combine
With medications
- !NSAIDs (Ibuprofen, etc.) - Can compound kidney stress - avoid during Adipotide use
- !ACE Inhibitors - May affect kidney function - monitor closely if combining
- !Diuretics - Increases dehydration risk significantly - avoid combination
- ✓Metformin - Generally safe but monitor kidney function more frequently
With supplements
- ✓Electrolytes - Highly recommended to maintain proper hydration and mineral balance
- ✓Protein supplements - Recommended to preserve muscle mass during rapid fat loss
- ✓Creatine - May confound creatinine monitoring - consider stopping during treatment
- ✓High-dose Vitamin C - Very high doses may affect kidney stone risk - use moderate amounts
Published Research
What the studies show
Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W · 2004
This foundational study discovered that the CKGGRAKDC peptide homes to white fat blood vessels by binding prohibitin. When linked to a cell-death-inducing sequence, it caused targeted destruction of fat tissue and rapid obesity reversal in mice without detectable side effects.
Barnhart KF, Christianson DR, Hanley PW, et al. · 2011
Obese rhesus monkeys lost an average of 11% body weight in just 4 weeks of treatment. MRI confirmed 17-27% reduction in white adipose tissue. Treated monkeys showed 50% improvement in insulin sensitivity. Kidney effects were predictable and fully reversible.
Kolonin MG, Pasqualini R, Arap W · 2011
This study validated the peptide screening platform used to discover Adipotide and demonstrated how targeting specific vascular markers can be used therapeutically. The approach has implications beyond obesity for targeted drug delivery.
Kim DH, Woods SC, Seeley RJ · 2010
Confirmed that the proapoptotic peptide targeting fat vasculature reduces food intake in addition to directly destroying fat tissue. This dual mechanism may contribute to its effectiveness for weight loss.
Head to Head
Adipotide compared
Want the Full Picture?
View the complete Adipotide research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.